Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 145,276 | 144,923 | 149,745 | 136,709 | 135,546 |
| Cost of Goods | 54,470 | 53,467 | 55,115 | 56,398 | 61,720 |
| Gross Profit | 90,806 | 91,456 | 94,630 | 80,311 | 73,826 |
| Operating Expenses | 43,805 | 42,449 | 33,057 | 35,696 | 38,913 |
| Operating Income | 47,471 | 49,474 | 61,688 | 45,013 | 35,633 |
| Interest Expense | 15,587 | 17,339 | 19,281 | 20,768 | 21,863 |
| Other Income | -2,787 | 4,487 | 4,303 | 4,538 | 4,027 |
| Pre-tax Income | 29,097 | 36,622 | 46,710 | 28,783 | 17,797 |
| Income Tax | 9,491 | 8,909 | 14,770 | 8,149 | 4,790 |
| Net Income Continuous | 19,606 | 27,713 | 31,940 | 20,634 | 13,007 |
| Net Income | $19,606 | $27,713 | $31,940 | $20,634 | $13,007 |
| EPS Basic Total Ops | 0.60 | 0.86 | 0.95 | 0.61 | 0.38 |
| EPS Basic Continuous Ops | 0.60 | 0.86 | 0.95 | 0.61 | 0.38 |
| EPS Diluted Total Ops | 0.52 | 0.71 | 0.93 | 0.53 | 0.34 |
| EPS Diluted Continuous Ops | 0.49 | 0.67 | 0.87 | 0.49 | 0.30 |
| EPS Diluted Before Non-Recurring Items | 1.43 | 1.32 | 1.45 | N/A | N/A |
| EBITDA(a) | $82,215 | $84,493 | $96,583 | $81,596 | $73,893 |